Was I referring to a capital raising or a closed placement? They are two very different things.
As for any retail capital raising, I would wait yes. We are in a strong financial position.
As for a placement, if the partner is right.
One thing PTX is missing is the financial backing of a strong institution. Knowing that Merchant Funds is willing to back Prescient now & possibly in future raisings would be a strong signal to retail investment...A massive vote of confidence if you will.
The most important thing to remember is, it doesn't much matter what I think threebeez....Merchant Funds are reporting they have taken a position...I've no reason to doubt their claim.
Secondly...Steven Yatomi-Clarke is a highly credentialed individual with degrees in both business & medicine...I'll trust in his stewardship before yours.
Despite being utterly humbled only weeks ago after rude & completely false claims against me...You still can't stop this unwarranted adversarial challenging? Consider yourself lucky I even respond but I'm both forgiving & generous with my time.
Enjoy your evening.
- Forums
- ASX - By Stock
- PTX
- PTX Media related
PTX Media related, page-337
-
- There are more pages in this discussion • 1,277 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.0¢ |
Change
0.004(8.70%) |
Mkt cap ! $40.26M |
Open | High | Low | Value | Volume |
4.6¢ | 5.0¢ | 4.6¢ | $25.37K | 515.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 40972 | 4.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.0¢ | 317119 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 40972 | 0.049 |
1 | 190413 | 0.048 |
1 | 25000 | 0.047 |
3 | 114980 | 0.046 |
1 | 25000 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.050 | 317119 | 4 |
0.051 | 227227 | 1 |
0.052 | 39540 | 1 |
0.053 | 112000 | 2 |
0.055 | 562700 | 4 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
NEWS
New gold and silver soil anomalies uncovered at Black Range, strengthening exploration potential
RCE
Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
PTX (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online